AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $50K-$100K of CRISPR Therapeutics AG (CRSP) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of CRISPR Therapeutics AG (CRSP) stock worth $50K-$100K in a STOCK Act filing on Dec 23, 2020.
The trade happened on Dec 22, 2020, 1 day before it was made public.
CRSP has moved -68.1% since the trade date, from $170.08 to $54.23 (Sep 25, 2026 close).
- Traded
- Dec 22, 2020
- Disclosed
- Dec 23, 2020
- Filing delay
- 1 day
- Price since
- -68.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
More CRSP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.